Saturday July 4 2009 | Biotechnology feed | All feeds
|
|
Connetics Corporation
Download detailed PDF Members: Connetics Corporation is a specialty pharmaceutical company focused on the development and commercialization of innovative therapeutics for the dermatology market. The Company's marketed products are OLUX® (clobetasol propionate) Foam, 0.05% and Luxiq® (betamethasone valerate) Foam, 0.12%, Evoclin™ (clindamycin phosphate) Foam 1%, and Soriatane® (acitretin) capsules. Connetics is developing Extina® , a foam formulation of the antifungal drug ketoconazole, Velac® Gel, a combination of clindamycin and tretinoin for treating acne, and Desilux™, a low-potency topical steroid, formulated with 0.05% desonide in the Company's proprietary emollient foam delivery vehicle. Connetics has branded its innovative foam drug delivery vehicle VersaFoam®. Our product formulations aim to improve the management of dermatological diseases and provide significant product differentiation, and have earned wide acceptance by both physicians and patients due to their clinical effectiveness, high quality and cosmetic elegance
This page has been viewed 460 times since April 2007, the link to the organisation's website has been followed 66 times Recent Search Terms used to find this page: connetics | connetics | connetics pharma contact | hplc | connetics pharmaceuticals | t | connetics roweville | Connetics Australia | desonide degradation | Emollient foam in topical drug delivery | . Search for more companies in Palo Alto Search for more companies in California This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Connetics Corporation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|